AI-generated
May 5, 2026, 08:45
Effectiveness and Safety of Concizumab in Hemophilia – CRH French Reference Center for Hemophilia Lyon
CRH French Reference Center for Hemophilia Lyon shared a post on LinkedIn about a recent article by Caroline Galeotti et al, published in Haemophilia, adding:
“Happy to share our French real-world experience with Concizumab — including in surgical settings.”
Title: Real-World Effectiveness and Safety of Concizumab Prophylaxis in Hemophilia: Results From a National French Cohort
Authors: Caroline Galeotti, Antoine Rauch, Helene Gatti, Stephanie Desage, Alexandre Butelet, Christine Biron-Andreani, Sophie Susen, Roseline d’Oiron, Guillaume Chanteau, Valerie Proulle, Yesim Dargaud
Stay updated on all scientific advances with Hemostasis Today.
Alexandre Butelet
Antoine Rauch
Caroline Galeotti
Christine Biron-Andreani
Concizumab
CRH French Reference Center for Hemophilia Lyon
Guillaume Chanteau
haemophilia
Health
Helene Gatti
Hematology
Hemostasis News
Hemostasis Today
Medicine
Roseline d'Oiron
Sophie Susen
Stephanie Desage
Valerie Proulle
Yesim Dargaud
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion